Healthcare & Medical Devices Global On demand · 24-48h

Global Multiparametric Test Strip Market Strategic Research Report

Global Multiparametric Test Strip Market Strategic Research …
$3,500 USD
Market Research Reports
Strategic Research Report
Global Multiparametric Test Strip Market
$1.42B2025
8.3%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Suitable For Animals, Suitable For Human

By Application: Hospital, Clinic, Laboratory, Others

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: Siemens Healthineers, Roche Diagnostics, Analyticon Biotechnologies, 77 Elektronika, MACHEREY-NAGEL, HUMAN Diagnostics, ACON Biotech Hangzhou, DIRUI Industrial, Mindray Bio-Medical Electronics, Guangzhou Wondfo Biotech, ChungDo Pharm, Cypress Diagnostics, AMEDA Labordiagnostik, TODA PHARMA, EUROIMMUN Medizinische Labordiagnostika, BIOSYNEX, BTNX, Teco Diagnostics, Fortress Diagnostics, Erba Lachema, Menarini Diagnostics

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 149 pages
Market size 2025
$1.42B
Billion USD
Forecast CAGR
8.3%
2025-2032
Forecast 2032
$2.5B
Projected
Regions
5
Asia Pacific · Latin America · MEA · Europe · North America

Overview

Scope of the Report

The global Multiparametric Test Strip market size is predicted to grow from US$ 1,418 million in 2025 to US$ 2,486 million in 2032; it is expected to grow at a CAGR of 8.3% from 2026 to 2032.

A Multiparametric Test Strip is an in vitro diagnostic consumable used for rapid qualitative or semi-quantitative screening of multiple analytes in urine. It is typically a narrow plastic strip carrying several discrete reagent pads, each impregnated with a specific dry-chemistry, enzymatic, indicator-based, or colorimetric reaction system. After brief immersion in a urine specimen, the reagent pads change color in response to the presence or concentration of analytes such as glucose, protein, ketones, bilirubin, urobilinogen, blood, leukocytes, nitrite, pH, specific gravity, ascorbic acid, microalbumin, creatinine, or calcium.

The result may be interpreted visually by comparing the reaction pads with a color chart within a defined reading time, or instrumentally by a urine chemistry analyzer using reflectance photometry. The product provides a low-cost, rapid, non-invasive screening method for urinary tract disorders, kidney conditions, diabetes-related metabolic changes, liver and biliary disorders, infection screening, and acid-base status.

Multiparametric Test Strip market opportunities are driven by the long-term stability of basic diagnostic demand. Multiparametric Test Strip is one of the most frequently used screening tests in healthcare systems worldwide because Multiparametric Test Strip samples are easy to collect, the procedure is rapid, and the cost is low. Rising prevalence of diabetes, chronic kidney disease, urinary tract infections, pregnancy-related risks, hepatobiliary disorders, and aging-related chronic disease management continues to expand Multiparametric Test Strip demand. Primary care clinics, health check-up centers, emergency departments, maternal care, elderly care facilities, and home-testing channels are extending Multiparametric Test Strip demand beyond central laboratories. Technological upgrades such as vitamin C interference resistance, microalbumin-creatinine testing, analyzer compatibility, smartphone-assisted reading, and digital result management are increasing Multiparametric Test Strip value.

The main challenges for Multiparametric Test Strip are price competition, quality consistency, and regulatory compliance. Basic ten- or eleven-parameter Multiparametric Test Strips are mature products, and competition among Asian manufacturers, established Western IVD companies, and home-testing brands has increased Multiparametric Test Strip pricing pressure. Although Multiparametric Test Strip appears simple, it requires precise reagent formulation, stable color development, humidity control, anti-interference design, sealed packaging, and lot-to-lot consistency. Poor stability may lead to false-negative or false-positive results and analyzer-reading deviations. Regulatory requirements for in vitro diagnostics, clinical performance, labeling, quality systems, and post-market surveillance are tightening in Europe, the United States, China, and other major markets.

Downstream demand for Multiparametric Test Strip is moving simultaneously toward professionalization, automation, and home use. Hospitals and reference laboratories prefer Multiparametric Test Strips that match automated urine analyzers and support consistent reading, barcode traceability, quality control, and laboratory information systems. Primary care and health-check institutions focus on ease of use, rapid turnaround, moderate pricing, and flexible Multiparametric Test Strip pack sizes. The home-testing channel values individually sealed Multiparametric Test Strips, clear instructions, smartphone-assisted interpretation, and privacy. Traditional ten-parameter Multiparametric Test Strips will remain mainstream, while higher-end Multiparametric Test Strips containing microalbumin, creatinine, calcium, or interference-correction pads will gradually increase their share.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Multiparametric Test Strip market?

What factors are driving Multiparametric Test Strip market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Multiparametric Test Strip market opportunities vary by end market size?

How does Multiparametric Test Strip break out by Type, by Application?

This report presents a comprehensive overview of the global Multiparametric Test Strip market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Suitable For Animals
  • Suitable For Human

Segment by Reading Method

  • Visual Reading Test Strip
  • Analyzer-readable Test Strip

Segment by Reaction Principle

  • Colorimetric Reagent Strip
  • Enzymatic Reagent Strip
  • Indicator-based Reagent Strip
  • Diazonium Reaction Reagent Strip

Segment by Application

  • Hospital
  • Clinic
  • Laboratory
  • Others

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Multiparametric Test Strip market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Hospital, Clinic, Laboratory evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Multiparametric Test Strip Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 8.3%
Regional growth momentum
Market share by segment
Key metrics
Base value
$1.42B
2025
Forecast
$2.5B
2032
CAGR
8.3%
2025–2032
Regions
5
global
Key companies
Siemens HealthineersRoche DiagnosticsAnalyticon Biotechnologies77 ElektronikaMACHEREY-NAGELHUMAN DiagnosticsACON Biotech HangzhouDIRUI Industrial
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
Suitable For AnimalsSuitable For Human
By Application
HospitalClinicLaboratoryOthers

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Suitable For Animals
  • 3.1.3 Suitable For Human
  • 3.1.4 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Hospital
  • 4.1.3 Clinic
  • 4.1.4 Laboratory
  • 4.1.5 Others
  • 4.1.6 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 Siemens Healthineers
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 Roche Diagnostics
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 Analyticon Biotechnologies
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 77 Elektronika
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 MACHEREY-NAGEL
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 HUMAN Diagnostics
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 ACON Biotech Hangzhou
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 DIRUI Industrial
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 Mindray Bio-Medical Electronics
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 Guangzhou Wondfo Biotech
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 ChungDo Pharm
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 Cypress Diagnostics
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
  • 8.13 AMEDA Labordiagnostik
  • 8.13.1 Company Overview
  • 8.13.2 Key Products & Segments
  • 8.13.3 Financial Performance (2023–2025)
  • 8.13.4 Business Strategy
  • 8.13.5 SWOT Analysis
  • 8.13.6 Strategic Implications (2026–2032)
  • 8.14 TODA PHARMA
  • 8.14.1 Company Overview
  • 8.14.2 Key Products & Segments
  • 8.14.3 Financial Performance (2023–2025)
  • 8.14.4 Business Strategy
  • 8.14.5 SWOT Analysis
  • 8.14.6 Strategic Implications (2026–2032)
  • 8.15 EUROIMMUN Medizinische Labordiagnostika
  • 8.15.1 Company Overview
  • 8.15.2 Key Products & Segments
  • 8.15.3 Financial Performance (2023–2025)
  • 8.15.4 Business Strategy
  • 8.15.5 SWOT Analysis
  • 8.15.6 Strategic Implications (2026–2032)
  • 8.16 BIOSYNEX
  • 8.16.1 Company Overview
  • 8.16.2 Key Products & Segments
  • 8.16.3 Financial Performance (2023–2025)
  • 8.16.4 Business Strategy
  • 8.16.5 SWOT Analysis
  • 8.16.6 Strategic Implications (2026–2032)
  • 8.17 BTNX
  • 8.17.1 Company Overview
  • 8.17.2 Key Products & Segments
  • 8.17.3 Financial Performance (2023–2025)
  • 8.17.4 Business Strategy
  • 8.17.5 SWOT Analysis
  • 8.17.6 Strategic Implications (2026–2032)
  • 8.18 Teco Diagnostics
  • 8.18.1 Company Overview
  • 8.18.2 Key Products & Segments
  • 8.18.3 Financial Performance (2023–2025)
  • 8.18.4 Business Strategy
  • 8.18.5 SWOT Analysis
  • 8.18.6 Strategic Implications (2026–2032)
  • 8.19 Fortress Diagnostics
  • 8.19.1 Company Overview
  • 8.19.2 Key Products & Segments
  • 8.19.3 Financial Performance (2023–2025)
  • 8.19.4 Business Strategy
  • 8.19.5 SWOT Analysis
  • 8.19.6 Strategic Implications (2026–2032)
  • 8.20 Erba Lachema
  • 8.20.1 Company Overview
  • 8.20.2 Key Products & Segments
  • 8.20.3 Financial Performance (2023–2025)
  • 8.20.4 Business Strategy
  • 8.20.5 SWOT Analysis
  • 8.20.6 Strategic Implications (2026–2032)
  • 8.21 Menarini Diagnostics
  • 8.21.1 Company Overview
  • 8.21.2 Key Products & Segments
  • 8.21.3 Financial Performance (2023–2025)
  • 8.21.4 Business Strategy
  • 8.21.5 SWOT Analysis
  • 8.21.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

What is the current global Multiparametric Test Strip market size?
The global Multiparametric Test Strip market is estimated at US$ 1.42 billion in 2025 (base year) and is projected to reach US$ 2.49 billion by 2032.
What growth rate is expected for the Multiparametric Test Strip market through 2032?
The market is expected to grow at a CAGR of 8.3% from 2026 to 2032, expanding from US$ 1.42 billion in 2025 to US$ 2.49 billion in 2032, roughly 1.8 times its base-year value.
How is Multiparametric Test Strip defined?
A Multiparametric Test Strip is an in vitro diagnostic consumable used for rapid qualitative or semi-quantitative screening of multiple analytes in urine. It is typically a narrow plastic strip carrying several discrete reagent pads, each impregnated with a specific dry-chemistry, enzymatic, indicator-based, or colorimetric reaction system.
What are the main segments of the Multiparametric Test Strip market by type?
By type, the market is segmented into Suitable For Animals and Suitable For Human.
Which applications drive demand in the Multiparametric Test Strip market?
Key applications covered include Hospital, Clinic, Laboratory and Others.
Who are the key players in the Multiparametric Test Strip market?
Key players profiled include Siemens Healthineers, Roche Diagnostics, Analyticon Biotechnologies, 77 Elektronika, MACHEREY-NAGEL, HUMAN Diagnostics, ACON Biotech Hangzhou and DIRUI Industrial, among 21 companies covered in total.
Which regions and countries are covered for Multiparametric Test Strip?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What is driving growth in the Multiparametric Test Strip market?
Multiparametric Test Strip market opportunities are driven by the long-term stability of basic diagnostic demand.
What challenges does the Multiparametric Test Strip market face?
The main challenges for Multiparametric Test Strip are price competition, quality consistency, and regulatory compliance.
Who should buy the Multiparametric Test Strip market report?
The report is intended for manufacturers and solution providers, distributors and end users in Hospital, Clinic and Laboratory, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Multiparametric Test Strip market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from $3,500.00
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.